5 With the limited published data, it is important to review current relevant literature and re-evaluate traditional fasting guidelines in patients taking GLP-1 and GLP-1/GIL receptor agonist medications
In addition to glycemic control, the market is increasingly being shaped by demand for obesity management and cardiometabolic risk reduction
The needs are complex
What happens if you get pregnant while taking GLP-1 RAs
Now, from celebrities to people you may personally know, the increase in prescriptions for these medications cant be understated
GLP-1 receptor agonists such as semaglutide, liraglutide, and dulaglutide, plus the GIP/GLP-1 dual agonist tirzepatide, act on appetite, satiety, and gastric emptying